Flash FinanceUS
After hours S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · Envoy Medical, Inc. (COCH)

Envoy Medical settles Atlas redemption lawsuit; Atlas claims dismissed with prejudice

Positive Impact 2 of 5 legal/regulatory Written later

Envoy Medical entered a Dismissal Agreement on October 6, 2026, resolving litigation in the Delaware Court of Chancery brought by Atlas Merchant Capital SPAC Fund I LP. Atlas had alleged it was not allowed to redeem its Class A Common Stock in the company's September 2023 business combination. Under the agreement, all Atlas claims will be dismissed with prejudice and neither the company nor any other defendant must make a payment to Atlas.

Key points

  • Agreement dated October 6, 2026, resolves Delaware Court of Chancery litigation with Atlas Merchant Capital SPAC Fund I LP
  • Atlas's claims will be dismissed with prejudice, with no further proceedings on the Litigation
  • No payment is required from Envoy Medical or any other defendant to Atlas under the agreement
  • Filing dated October 7, 2026, signed by CEO Brent Lucas

The filing

CompanyEnvoy Medical, Inc. (COCH)
Form8-K, current report
Filed with the SECOct 7, 2026, 9:00 AM ET
Accession number0001213900-26-107434

Items reported: 8.01 Other Events

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 11:44 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on October 07, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.